Skip to main content
GB

GitLife Biotech

GitLife Biotech provides a version control system for synthetic biology through its CellRepo™ platform, which organizes and secures data generated during strain engineering processes. This technology enhances traceability and ownership of biological assets by linking digital records to unique DNA Genosignatures®, ensuring precise documentation and compliance in genetic engineering.

Newcastle, South AfricaFounded 202391K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Synthetic biology and strain engineering processes generate large volumes of data that are often managed using spreadsheets and siloed systems, leading to challenges in data traceability, IP protection, and collaboration. This lack of structured data management hinders the ability to track changes, secure biological assets, and ensure compliance with evolving biosecurity standards.

Solution

GitLife Biotech offers CellRepo™, a version control and biosecurity system designed for synthetic biology, which catalogs and secures digital information generated throughout the strain engineering process. CellRepo™ acts as a central platform to organize data, enhance transparency, and foster responsibility in research procedures. The platform allows users to track and retrieve modifications, significantly enhancing the management of biological assets. Upon request, CellRepo™ can generate a unique DNA Genosignature® for each digital entry, physically linking cell samples with digital records of their construction and ownership, which is crucial for asserting intellectual property rights.

Target Audience

GitLife Biotech targets biotech startups, synthetic biology companies, research labs, and commercial leads who need to manage and protect their biological assets, streamline collaboration, and ensure compliance.

Features

  • Version control for biological assets, including engineered strains, protocols, and constructs
  • DNA-level barcoding (Genosignatures™) for IP traceability, linking organisms to CellRepo records
  • Secure, auditable collaboration across teams and partners with lineage tracking and contribution logs
  • Tools for managing licensing terms, usage rights, and ownership of biological assets
  • Integration of biosecurity measures, including cryptographic watermarking and IP governance
  • Capabilities for tracking and versioning biological assets, from engineered strains to protocols and constructs
This profile is AI-generated and may contain inaccuracies.